Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 18
Selected: 0
NCT IDTitle
NCT03010631Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers
NCT01379560A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration
NCT00595946Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
NCT00452335Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
NCT01298219Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)
NCT00597818Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury
NCT02138136Lubiprostone for Children With Constipation
NCT01993875Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation
NCT00399542Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
NCT00380250Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
NCT02544152Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
NCT00737594Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
NCT02542215Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy
NCT00597428Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone
NCT00620061Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
NCT02042183Lubiprostone in Children With Functional Constipation
NCT03097861Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo
NCT02766777Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional Constipation